Literature DB >> 4378113

Vesicular stomatitis virus in Panama. Human serologic patterns in a cattle raising area.

J A Brody, G F Fischer, P H Peralta.   

Abstract

Entities:  

Mesh：

Year:  1967        PMID： 4378113     DOI： 10.1093/oxfordjournals.aje.a120721

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN： 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  15 in total

1.  Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins.

Authors:  Blair L DeBuysscher; Dana Scott; Andrea Marzi; Joseph Prescott; Heinz Feldmann
Journal:  Vaccine       Date:  2014-03-12       Impact factor: 3.641

Review 2.  Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections.

Authors:  Thomas W Geisbert; Heinz Feldmann
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

Review 3.  From bench to almost bedside: the long road to a licensed Ebola virus vaccine.

Authors:  Gary Wong; Emelissa J Mendoza; Francis A Plummer; George F Gao; Gary P Kobinger; Xiangguo Qiu
Journal:  Expert Opin Biol Ther       Date:  2017-11-17       Impact factor: 4.388

4.  Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge.

Authors:  A Roberts; E Kretzschmar; A S Perkins; J Forman; R Price; L Buonocore; Y Kawaoka; J K Rose
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

5.  Molecular weight estimates of vesicular stomatitis virus ribonucleic acids from virions, defective particles, and infected cells.

Authors:  F L Schaffer; M E Soergel
Journal:  Arch Gesamte Virusforsch       Date:  1972

6.  Creation of matrix protein gene variants of two serotypes of vesicular stomatitis virus as prime-boost vaccine vectors.

Authors:  Gyoung Nyoun Kim; Kunyu Wu; Jiho Patrick Hong; Zain Awamleh; C Yong Kang
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

7.  Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus.

Authors:  Kyle S Brown; David Safronetz; Andrea Marzi; Hideki Ebihara; Heinz Feldmann
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

8.  Pre-clinical development of a vaccine against Lassa fever.

Authors:  L Banadyga; D R Stein; X Qiu; D Safronetz
Journal:  Can Commun Dis Rep       Date:  2018-06-07

9.  In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculation.

Authors:  J Erik Johnson; John W Coleman; Narender K Kalyan; Priscilla Calderon; Kevin J Wright; Jennifer Obregon; Eleanor Ogin-Wilson; Robert J Natuk; David K Clarke; Stephen A Udem; David Cooper; R Michael Hendry
Journal:  Vaccine       Date:  2009-03-13       Impact factor: 3.641

10.  Vesicular stomatitis virus with the rabies virus glycoprotein directs retrograde transsynaptic transport among neurons in vivo.

Authors:  Kevin T Beier; Arpiar B Saunders; Ian A Oldenburg; Bernardo L Sabatini; Constance L Cepko
Journal:  Front Neural Circuits       Date:  2013-02-07       Impact factor: 3.492
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.